Correlation of Genetic Polymorphism of CYP3A5 to Cyclophosphamide Efficacy and Toxicity in Rhabdomyosarcoma Pediatric Egyptian Cancer Patients

Volume 25, Issue 7, July 2024, Pages 2445-2455

Cherine E. ElShereef; Hala F. Zaki; Osama A. Badary; Sherif Kamal; Mohamed Nagy; Dalia Makhlouf; Mohamed Kamal; Inas Elnadi; Sameh A.Abdelshafi; Sherif Abou El Naga; Mona M Saber

• View Article
• PDF 822.98 K

Pharmacogenetic Study of the Dihydropyridine Dehydrogenase Gene in Jordanian Patients with Colorectal Cancer

Volume 23, Issue 9, September 2022, Pages 3061-3069

Nusaiba A Almashagbah; Amjad A Mahasneh; khaldon G Bodoor

• View Article
• PDF 773.07 K

Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan

Volume 19, Issue 1, January 2018, Pages 199-205

Mervat Alsous; Al-Motassem Yousef; Mariam Abdel Jalil; Mohammed Zawiah; Shorouq Yacoub; Deema Momani; Alia Gharabli; Suha Omar; Rawad Rihani

• View Article
• PDF 435.78 K

Genetic Polymorphism of Drug Metabolizing Enzymes inAssociation with Risk of Bile Duct Cancer

Volume 13, KKSuppl, December 2012, Pages 7-15

• View Article
• PDF 553.68 K

Impact of CYP2D6 Polymorphisms on Tamoxifen Responses of Women with Breast Cancer: A Microarray-based Study in Thailand

Volume 13, Issue 9, September 2012, Pages 4549-4553

• View Article
• PDF 504.4 K

Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients

Volume 13, Issue 4, April 2012, Pages 1553-1556

• View Article
• PDF 352.65 K

Genomics and Pharmacogenomics of Breast Cancer: Current Knowledge and Trends

Volume 12, Issue 5, May 2011, Pages 1127-1140

• View Article
• PDF 674.66 K